Reducing differences in the uptake of immunisations: consultation on the evidence
NICE was asked by the Department of Health (DH) to develop public health intervention guidance to reduce differences in the uptake of immunisations (including targeted vaccines) in children and young people aged under 19 years.
All registered stakeholders are now invited to comment on the evidence that has been assembled to inform the development of this guidance. This evidence will be used by the Public Health Interventions Advisory Committee (PHIAC) to develop draft recommendations. The evidence comprises a review of effectiveness and cost effectiveness incorporating a review of qualitative evidence. An economic analysis will be issued for consultation in January 2009.
Key areas for comment:
The aim of this consultation is to enable stakeholders to consider the evidence gathered and to provide the opportunity to comment, in particular on:
- major gaps in the evidence gathered, including papers in the published literature that we have not been able to identify
- queries around the interpretation of the evidence, both of single studies and the reviewed material as a whole
- the applicability of the evidence and its usefulness for the development of guidance
- issues relating to equality
- issues relating to cost-effectiveness.
Registered stakeholders are also invited to submit relevant additional evidence for consideration. In order for NICE to be able to produce guidance in a timely fashion, materials should be:
- relevant to the questions set out in the scope document
- currently not included in the evidence reviews
- provided as a PDF or electronic link to an accessible version of the complete document.
(If it is not possible to submit additional evidence electronically, please contact the Project Co-ordinator to make alternative arrangements.)
Any material submitted by stakeholders during this consultation will be assessed for its relevance using NICE's standard methods, as set out in the 'Methods for development of NICE public health guidance'. Relevant material will be included in a supplementary report to the PDG.
The consultation on this evidence will run from 24 September to 22 October 2008.
Please provide all responses to this consultation on the of evidence electronically using the Stakeholder Comments Form (ensuring all relevant fields are completed, including your organisation's name) and forward this, along with any additional evidence you are submitting, by 5pm on Wednesday 22 October 2008 at the very latest to email@example.com
The review of effectiveness and cost effectiveness was carried out by the National Collaborating Centre for Women?s and Children?s Health.
Please note, the evidence presented here does not constitute NICE's guidance on this topic. NICE will issue draft guidance to reduce the differences in immunisation uptake in January 2009.
This page was last updated: 30 March 2010